STRO · Sutro Biopharma, Inc. · Webcasts, Transcripts & Audio
$9.20
-0.74 (-7.44%)
At close · Nov 5
Return incl. dividend (before tax)
Market Cap
$153.71M
Shares
16.58M
Volume · Nov 5
771.86K
Avg daily vol (3M)
319.6K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Sutro Biopharma, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Sutro Biopharma, Inc. (STRO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-18
Sutro Biopharma, Inc. (STRO) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-11
Sutro Biopharma, Inc. (STRO) November 11, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-12
Sutro Biopharma, Inc. (STRO) Q2 2026 Earnings Call
Revenue
$9.84M
▼ 84.6% YoY Diluted EPS
$-2.33
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-06-05
Sutro Biopharma, Inc. (STRO) June 5, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-04
Sutro Biopharma, Inc. (STRO) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-27
Sutro Biopharma, Inc. (STRO) Q1 2026 Earnings Call
Revenue
$14.52M
▼ 16.5% YoY Diluted EPS
$-2.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q3
2025-11-06
Sutro Biopharma, Inc. (STRO) Q3 2025 Earnings Call
Revenue
$9.69M
▲ 13.8% YoY Diluted EPS
$-6.70
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Sutro Biopharma, Inc. (STRO) Q2 2025 Earnings Call
Revenue
$63.74M
▲ 148% YoY Diluted EPS
$-1.35
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Sutro Biopharma, Inc. (STRO) Q1 2025 Earnings Call
Revenue
$17.40M
▲ 33.8% YoY Diluted EPS
$-9.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-13
Sutro Biopharma, Inc. (STRO) Q4 2024 Earnings Call
Revenue
$14.81M*
▼ 87% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Sutro Biopharma, Inc. (STRO) Q3 2024 Earnings Call
Revenue
$8.52M
▼ 49.7% YoY Diluted EPS
$-5.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Sutro Biopharma, Inc. (STRO) Q2 2024 Earnings Call
Revenue
$25.71M
▲ 146.9% YoY Diluted EPS
$-5.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Sutro Biopharma, Inc. (STRO) Q1 2024 Earnings Call
Revenue
$13.01M
▲ 2.6% YoY Diluted EPS
$-5.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-25
Sutro Biopharma, Inc. (STRO) Q4 2023 Earnings Call
Revenue
$113.72M*
▲ 1217.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Sutro Biopharma, Inc. (STRO) Q3 2023 Earnings Call
Revenue
$16.92M
▼ 32.7% YoY Diluted EPS
$-8.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-27
Sutro Biopharma, Inc. (STRO) Q1 2020 Earnings Call
Revenue
$7.15M
▼ 17.1% YoY Diluted EPS
$-8.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–16 of 16 webcasts
Key facts
CIK
1382101
CUSIP
869367201
13F (30d)
31 filings
19 filers
Visit website
Investor relations